Latest in diagnostics in EGFR mutated NSCLC

Share :
This content is restricted to members who are registered with ecancer as a healthcare professional
Please login or register for free to confirm your details.
Published: 3 Dec 2021
Views: 1742
Dr Neal Lindeman - Brigham and Women's Hospital, Boston, USA

Dr Neal Lindeman speaks to ecancer about non-small cell lung cancer pathology.

Initially, he discusses the latest state of play in diagnostics in EGFR mutated NSCLC.

He then talks about the unmet needs and challenges in this diagnostic setting.

Dr Lindeman mentions some recommended methods for NSCLC identification and diagnostics and explains the current testing methods for EGFR uncommon mutations such as EGFR exon 20 insertions.

He concludes by talking about comprehensive molecular testing for NSCLC with EGFR mutations and what the future looks like for diagnosing this type of lung cancer.

This programme has been supported by an unrestricted educational grant from Takeda